Literature DB >> 21339905

The effects of deep brain stimulation on sleep in Parkinson's disease.

Amy W Amara1, Ray L Watts, Harrison C Walker.   

Abstract

Sleep dysfunction is a common nonmotor symptom experienced by patients with Parkinson's disease (PD). Symptoms, including excessive daytime sleepiness, sleep fragmentation, rapid eye movement (REM) sleep behavior disorder and others, can significantly affect quality of life and daytime functioning in these patients. Recent studies have evaluated the effects of deep brain stimulation (DBS) at various targets on sleep in patients with advanced PD. Several of these studies have provided evidence that subthalamic nucleus DBS improves subjective and objective measures of sleep, including sleep efficiency, nocturnal mobility, and wake after sleep onset (minutes spent awake after initial sleep onset). Although fewer studies have investigated the effects of bilateral internal globus pallidus and thalamic ventral intermedius DBS on sleep, pallidal stimulation does appear to improve subjective sleep quality. Stimulation of the pedunculopontine nucleus has recently been proposed for selected patients with advanced PD to treat severe gait and postural dysfunction. Owing to the role of the pedunculopontine nucleus in modulating behavioral state, the impact of stimulation at this target on sleep has also been evaluated in a small number of patients, showing that pedunculopontine nucleus DBS increases REM sleep. In this review, we discuss the effects of stimulation at these various targets on sleep in patients with PD. Studying the effects of DBS on sleep can enhance our understanding of the pathophysiology of sleep disorders, provide strategies for optimizing clinical benefit from DBS, and may eventually guide novel therapies for sleep dysfunction.

Entities:  

Keywords:  Parkinson’s disease; deep brain stimulation; globus pallidus; pedunculopontine nucleus; sleep; subthalamic nucleus; ventral intermediate nucleus of the thalamus

Year:  2011        PMID: 21339905      PMCID: PMC3036959          DOI: 10.1177/1756285610392446

Source DB:  PubMed          Journal:  Ther Adv Neurol Disord        ISSN: 1756-2856            Impact factor:   6.570


  90 in total

1.  The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease.

Authors:  K R Chaudhuri; S Pal; A DiMarco; C Whately-Smith; K Bridgman; R Mathew; F R Pezzela; A Forbes; B Högl; C Trenkwalder
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

2.  Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease.

Authors:  Jan Herzog; Jens Volkmann; Paul Krack; Florian Kopper; Monika Pötter; Delia Lorenz; Meike Steinbach; Stefan Klebe; Wolfgang Hamel; Bettina Schrader; Dieter Weinert; Dieter Müller; Hubertus M Mehdorn; Günther Deuschl
Journal:  Mov Disord       Date:  2003-11       Impact factor: 10.338

3.  Long-term follow up of subthalamic nucleus stimulation in Parkinson's disease.

Authors:  L M A Romito; M Scerrati; M F Contarino; A R Bentivoglio; P Tonali; A Albanese
Journal:  Neurology       Date:  2002-05-28       Impact factor: 9.910

4.  Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease.

Authors:  J A Obeso; C W Olanow; M C Rodriguez-Oroz; P Krack; R Kumar; A E Lang
Journal:  N Engl J Med       Date:  2001-09-27       Impact factor: 91.245

Review 5.  The pedunculopontine nucleus and Parkinson's disease.

Authors:  P A Pahapill; A M Lozano
Journal:  Brain       Date:  2000-09       Impact factor: 13.501

6.  Effect of chronic pallidal deep brain stimulation on off period dystonia and sensory symptoms in advanced Parkinson's disease.

Authors:  T J Loher; J-M Burgunder; S Weber; R Sommerhalder; J K Krauss
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-10       Impact factor: 10.154

7.  Subthalamic nucleus stimulation in advanced Parkinson's disease: blinded assessments at one year follow up.

Authors:  B Ford; L Winfield; S L Pullman; S J Frucht; Y Du; P Greene; J H Cheringal; Q Yu; L J Cote; S Fahn; G M McKhann; R R Goodman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-09       Impact factor: 10.154

8.  Different effects of unilateral versus bilateral subthalamic nucleus stimulation on walking and reaching in Parkinson's disease.

Authors:  Amy J Bastian; Valerie E Kelly; Fredy J Revilla; Joel S Perlmutter; Jonathan W Mink
Journal:  Mov Disord       Date:  2003-09       Impact factor: 10.338

9.  Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.

Authors:  Paul Krack; Alina Batir; Nadège Van Blercom; Stephan Chabardes; Valérie Fraix; Claire Ardouin; Adnan Koudsie; Patricia Dowsey Limousin; Abdelhamid Benazzouz; Jean François LeBas; Alim-Louis Benabid; Pierre Pollak
Journal:  N Engl J Med       Date:  2003-11-13       Impact factor: 91.245

10.  Reversal of akinesia in experimental parkinsonism by GABA antagonist microinjections in the pedunculopontine nucleus.

Authors:  Dipankar Nandi; Tipu Z Aziz; Nir Giladi; Jonathan Winter; John F Stein
Journal:  Brain       Date:  2002-11       Impact factor: 13.501

View more
  16 in total

1.  Nonmotor outcomes in Parkinson's disease: is deep brain stimulation better than dopamine replacement therapy?

Authors:  Rupam Borgohain; Rukmini Mridula Kandadai; Afshan Jabeen; Meena A Kannikannan
Journal:  Ther Adv Neurol Disord       Date:  2012-01       Impact factor: 6.570

Review 2.  Excessive daytime sleepiness and unintended sleep episodes associated with Parkinson's disease.

Authors:  Fatai Salawu; Abdulfatai Olokoba
Journal:  Oman Med J       Date:  2015-01

Review 3.  Disturbances of Sleep and Alertness in Parkinson's Disease.

Authors:  Aleksandar Videnovic
Journal:  Curr Neurol Neurosci Rep       Date:  2018-04-19       Impact factor: 5.081

Review 4.  Management of sleep disorders in Parkinson's disease and multiple system atrophy.

Authors:  Aleksandar Videnovic
Journal:  Mov Disord       Date:  2017-01-24       Impact factor: 10.338

5.  Amelioration of L-Dopa-Associated Dyskinesias with Triterpenoic Acid in a Parkinsonian Rat Model.

Authors:  Babongile C Ndlovu; Willie M U Daniels; Musa V Mabandla
Journal:  Neurotox Res       Date:  2015-10-12       Impact factor: 3.911

6.  Movement- and behavioral state-dependent activity of pontine reticulospinal neurons.

Authors:  S Thankachan; P M Fuller; J Lu
Journal:  Neuroscience       Date:  2012-07-13       Impact factor: 3.590

Review 7.  Nonmotor Symptoms and Subthalamic Deep Brain Stimulation in Parkinson's Disease.

Authors:  Han-Joon Kim; Beom S Jeon; Sun Ha Paek
Journal:  J Mov Disord       Date:  2015-05-31

8.  An update of the classical and novel methods used for measuring fast neurotransmitters during normal and brain altered function.

Authors:  Victor Hugo Cifuentes Castro; Carmen Lucía López Valenzuela; Juan Carlos Salazar Sánchez; Kenia Pardo Peña; Silvia J López Pérez; Jorge Ortega Ibarra; Alberto Morales Villagrán
Journal:  Curr Neuropharmacol       Date:  2014-12       Impact factor: 7.363

9.  A Pilot Study Assessing the Effects of Pallidal Deep Brain Stimulation on Sleep Quality and Polysomnography in Parkinson's Patients.

Authors:  Christopher M Tolleson; Kanika Bagai; Arthur S Walters; Thomas L Davis
Journal:  Neuromodulation       Date:  2016-05-17

10.  Timing of deep brain stimulation in Parkinson disease: a need for reappraisal?

Authors:  Ruth-Mary deSouza; Elena Moro; Anthony E Lang; Anthony H V Schapira
Journal:  Ann Neurol       Date:  2013-05       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.